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Background
CD4+ T helper cells play a crucial role in the orchestration
of the immune system. While CD4+ Th1 responses pro-
vide important helper signals to the survival and matura-
tion of CD8+ T cells, CD4+ Th2 responses are involved in
B cell maturation and antibody class switching. However,
very little is known about the role and contribution of
HIV-1-specific CD4+ T helper responses to the control of
viral replication. Here we show that the presence of Gag-
specific CD4+ Th1 responses and Th2 responses against
Env are associated with viral control, while changes in this
pattern are associated with disease progression.
Methods
We cross-sectionally screened 21 subjects with chronic
HIV-1 infection (>10,000 copies/mL) and 15 elite con-
trollers (<50 copies/mL) for HIV-1-specific CD4+ T helper
responses by flow cytometry before and after cultivation
in helper subset polarizing conditions (Th1: IFNγ/IL12;
Th2: IL4/anti-IFNγ; Th17: anti-IL4/anti-IFNγ/TGFβ/IL6).
Results
HIV-1-specific CD4+ T helper responses were detected in
similar frequencies in chronic HIV-1 infection and elite
controllers. However, we observed in HIV-1 elite control-
lers significantly more CD4+ T cell responses consisting of
a Th1 (IFNγ+/IL2+) CD4+ T cell phenotype. These
responses were predominantly directed against the HIV-1
Gag protein. In contrast, in subjects with chronic-progres-
sive HIV-1 infection Th1 responses were directed against
envelope in a higher frequency (p < 0.02). Interestingly,
while the HIV-1-specific Th2 responses in elite controllers
were preferentially directed against envelope, we observed
a skewed over-representation of Th2 responses against
Gag in subjects with chronic-progressive HIV-1 infection.
These responses were also associated with higher activa-
tion levels.
Conclusion
Our data suggest that the presence of a distinct CD4+ T
helper cell pattern is associated with viral control. The
presence of Gag-specific Th1 responses and Env-specific
Th2 responses suggests a potential important role for the
helper signals for B and T cell responses. This finding
might be highly important for vaccine design.
from AIDS Vaccine 2009
Paris, France. 19–22 October 2009
Published: 22 October 2009
Retrovirology 2009, 6(Suppl 3):P260 doi:10.1186/1742-4690-6-S3-P260
<supplement> <title> <p>AIDS Vaccine 2009</p> </title> <editor>Anna Laura Ross</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1742-4690-6-S3-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1471-2105-10-S12-info.pdf</url> </supplement>
This abstract is available from: http://www.retrovirology.com/content/6/S3/P260
© 2009 Chevalier et al; licensee BioMed Central Ltd. 